Most people, when they imagine getting old, picture the last decade or two: the slowdown, the medications, the limitations, the loss of independence. We assume that's the price of admission for a long life. It isn't.
The difference between lifespan — how many years you live — and healthspan — how many of those years you live functional, mentally clear, and engaged — is, in many ways, the entire point of longevity medicine.
The compression of morbidity
The phrase comes from physician James Fries, who in 1980 made an observation that's still the central thesis of preventive medicine: if we can delay the onset of chronic disease faster than we extend life, we shrink the period of decline at the end. We compress morbidity into a smaller window. Most of life is healthy; the unhealthy part is short.
The opposite scenario — extending lifespan without extending healthspan — is the nightmare. More years of medications, immobility, cognitive decline, and dependence. Living longer in worse shape is not a win.
What actually drives healthspan
Peter Attia talks about the "four horsemen" of premature death and disability in adults: cardiovascular disease, metabolic dysfunction (insulin resistance and type 2 diabetes), neurodegeneration (Alzheimer's and related dementias), and cancer. With rare exception, these are what take healthspan away. They are interconnected — fix the metabolic side and you reduce risk on all four — and they are largely modifiable.
The leverage is in the early decades. Most of what determines how you age in your 60s, 70s, and 80s is happening in your 30s, 40s, and 50s, silently. By the time these diseases are clinically obvious, the train has been moving for 10 to 30 years. Longevity medicine is, at its core, the discipline of looking earlier, measuring better, and intervening sooner.
Two patients, two trajectories
Patient A is 75, walks three miles a day, plays with her grandkids on the floor, takes one medication, has all her cognition. Patient B is 75, requires help with stairs, takes seven medications, has had a TIA, and is in early cognitive decline. Both will probably die at roughly the same age. Their last decade looks completely different.
The interventions that separate Patient A from Patient B were, mostly, decisions made decades earlier. Body composition. Resistance training. Sleep. Lipid management. Insulin sensitivity. Blood pressure. Cancer screening. None of these are exotic. All of them are doable. The system just isn't built to nudge you toward them on the timeline that matters.
What we measure
The standard physical measures the things we know how to bill for: a basic lipid panel, an HbA1c if you're at risk, a blood pressure cuff. The metrics that actually predict trajectory — ApoB and Lp(a) for cardiovascular disease, fasting insulin for metabolic health, body composition with visceral fat trending, inflammatory markers, biological age — are not standard.
That's the gap longevity medicine is built to fill. Not as a replacement for primary care, but alongside it: looking at the markers your PCP doesn't routinely order, with the time to actually interpret them and build a plan that matters over the next 20 years, not the next 20 minutes.
The simple framing
The question isn't "how long will I live?" The question is: what do I want to be able to do at 80? Lift my grandkids. Travel. Hike. Stay sharp. Live independently. Those answers should drive the protocol. Aim for the function you want at 80, then work backwards on what needs to be true at 70, 60, 50, 40 to get there.
If you're reading this in your 30s or 40s and thinking "I'll deal with that later," the data is unfortunately clear: later is too late. The leverage is now.
Want to apply this to your own protocol? Start with a consultation.
Book at TWW →